Back to top

Nuvectis Pharma receives marketing approval in China for ciprocopan

Nuvectis Pharma (NVCT) announced that ciprocopan, a once-daily oral complement Factor B inhibitor, received marketing approval from the National Me...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nuvectis Pharma, Inc. (NVCT)